Professor, Medicine (Oncology)
Professor, Obstetrics & Gynecology and Women's Health
Associate Director, Clinical Research, Albert Einstein Cancer Center
Associate Chairman, Medical Oncology, Montefiore Einstein Center for Cancer Care
Breast cancerClinical TrialsHIV-associated cancers
Dr. Sparano is a clinical researcher who develops and evaluates new treatment approaches for breast cancer, lymphoma, and other cancers, including cancers associated with HIV infection. He also identifies genes that can be used to determine breast cancer prognosis and predict response to treatment – and that may be targeted in cancer as a treatment. He was involved in developing the Oncotype DCIS test, which provides patients with ductal carcinoma in situ of the breast a score that predicts the likelihood of recurrence after surgery, allowing the treatment program to be individualized. read more...
Professor, Surgery, Einstein
Chief, Transplantation, Montefiore Einstein Center for Transplantation
Director, Abdominal Organ Transplantation, Department of Surgery, Montefiore Einstein Center for Cancer Care
Liver diseasesTransplantationStem cell research
Dr. Kinkhabwala is an active member of Einstein’s NIH-funded Marion Bessin Liver Research Center, where he is working to develop new treatments derived from stem cells for liver diseases, including liver cancer. An expert in complex liver surgery, including liver transplantation, he helped establish the Montefiore Einstein Center for Transplantation, where physicians, surgeons, nurses and other clinicians work with scientists to deliver integrated care for patients with organ failure. read more...
Professor and Vice Chair for Translational Research, Department of Pediatrics, Einstein
Professor, Microbiology & Immunology, Einstein
Professor, Epidemiology and Population Health, Einstein
Attending Physician, Pediatrics, The Children's Hospital at Montefiore
Human papillomavirus (HPV)Cervical cancer screeningMolecular evolution
Dr. Burk is an authority on the genomics and evolution of human papillomaviruses (HPV), which cause nearly all cases of cervical cancer. His team was the first to report, in the New England Journal of Medicine, that the vast majority of HPV infections in young women are short-lived and don’t require treatment. More recently, his lab is utilizing Next-Gen sequencing to study papillomavirus genomics and methylation of the viral genome. His lab utilized this new technology to identify HPV16 and beta- and gamma-HPVs associated with head and neck squamous cell cancers (HNSCCs). read more...